Congo-Kinshasa: Potential New Ebola Drugs Being Trialled in MSF Treatment Centres

The Government of Democratic Republic of the Congo, with the support of WHO and partners, carried out a vaccination campaign in high-risk populations against Ebola virus disease in affected health zones.
press release

Four potential new treatments for Ebola are being used in a randomised controlled trial (RCT) at the Ebola Treatment Centres operated by Médecins Sans Frontières (MSF) in Katwa and Butembo, in North Kivu province, Democratic Republic of Congo (DRC).

The trial, being run in collaboration with the Ministry of Health, originally began in November 2018 in another treatment centre in the region, and MSF facilities are now able to contribute to providing valuable information on these developmental drugs.

The treatments that will be used in the RCT are drugs remdesivir, mAb114, REGN-EB3 and ZMapp. They have been offered to patients since the beginning of the current Ebola outbreak under Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) protocols.

The switch from MEURI protocols to a clinical trial is a critical step, as a clinical trial can generate the scientific data needed to draw conclusions on how effective these treatments are. The main objective of the trial is to identify the most effective of the four products to treat Ebola patients.

The trial is overseen by a steering committee convened by the World Health Organization and led by the National Institute of Biomedical Research of DRC (INRB) and the US National Institute of Health (NIH) in collaboration with other national and international organisations.

Butembo and Katwa are currently the hotspots of the Ebola epidemic that was declared in DRC on 1 August 2018.

The Butembo treatment centre can admit 96 people, while the one in Katwa, which opened last month, has a 62-bed capacity. Since they opened, MSF has admitted more than 2,100 patients to these two centres, of which 250 were confirmed cases, with 110 people recovering.

See What Everyone is Watching

More From: MSF

Don't Miss

AllAfrica publishes around 700 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.